ICG, the global alternative asset manager, has opened its its first Swiss office, located in Zurich. The office opening coincides with the appointment of Jürg Rimle as a Managing Director within its Client Solutions Group.
Global alternative investment firm Investcorp has appointed Vivek Agarwal as Senior Operating Partner for its India operations. Agarwal will lead the firm’s strategic expansion into opportunities in the software and software services sectors.
Haynes Boone has boosted its fund finance capabilities by adding seven attorneys from Seward & Kissel, as it positions to capitalise on growing demand for synthetic risk transfers, collateralised fund obligations, and securitised subscription lines.
Gresham House Ventures, a growth equity investor specialising in software and digitally driven businesses in the consumer, healthcare and service sectors, has appointed Marieke Christmann as Portfolio Director as the firm continues to strengthen its venture capital capabilities.
Some 86% of private equity firms expect alternative investments to dominate retail portfolios within the next five years, according to a new report based on a study commissioned by global asset servicing provider Apex Group.
Buyout firm Bain Capital has made a £1.1bn ($1.39bn) bid to acquire UK defence contractor Chemring Group, with shares in the London-listed business surging by over 16% on the news, according to a report by Reuters.
Seasoned collateralised loan obligation investor Wellington Management has held the final close of its inaugural CLO partners fund with $194m of capital commitments, including $27m from affiliates.
Tikehau Capital, along with Amundi Private Equity Funds, investors from Credit Agricole group — including IDIA Capital Investissement — and Arkéa Capital, have entered into exclusive discussions with Loar Group over a deal for LMB Aerospace.
Hong Kong-based CK Infrastructure has made a £7bn ($8.86bn) bid for a majority stake in troubled UK utility company Thames Water, in excess of a $5bn offer tabled by private equity giant KKR for the water supplier, according to a report by the Financial Times.
Gene therapy maker bluebird bio has agreed to be taken private by private equity firm Carlyle Group and SK Capital Partners in a cut-rate deal, amid a prolonged cash crunch struggle stemming from a challenging market for its products, according to a report by Reuters.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
